Literature DB >> 10363646

Are there multiple proteolytic pathways contributing to c-Fos, c-Jun and p53 protein degradation in vivo?

C Salvat1, C Aquaviva, I Jariel-Encontre, P Ferrara, M Pariat, A M Steff, S Carillo, M Piechaczyk.   

Abstract

The c-Fos and c-Jun oncoproteins and the p53 tumor suppressor protein are short-lived transcription factors. Several catabolic pathways contribute to their degradation in vivo. c-Fos and c-Jun are thus mostly degraded by the proteasome, but there is indirect evidence that, under certain experimental/physiological conditions, calpains participate in their destruction, at least to a limited extent. Lysosomes have also been reported to participate in the destruction of c-Fos. Along the same lines, p53 is mostly degraded following the ubiquitin/proteasome pathway and calpains also seem to participate in its degradation. Moreover, c-Fos, c-Jun and p53 turnovers are regulated upon activation of intracellular signalling cascades. All taken together, these observations underline the complexity of the mechanisms responsible for the selective destruction of proteins within cells.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10363646     DOI: 10.1023/a:1006960021281

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  32 in total

Review 1.  Structure and functions of the 20S and 26S proteasomes.

Authors:  O Coux; K Tanaka; A L Goldberg
Journal:  Annu Rev Biochem       Date:  1996       Impact factor: 23.643

2.  Proteolysis by calpains: a possible contribution to degradation of p53.

Authors:  M Pariat; S Carillo; M Molinari; C Salvat; L Debüssche; L Bracco; J Milner; M Piechaczyk
Journal:  Mol Cell Biol       Date:  1997-05       Impact factor: 4.272

3.  Ubiquitinylation is not an absolute requirement for degradation of c-Jun protein by the 26 S proteasome.

Authors:  I Jariel-Encontre; M Pariat; F Martin; S Carillo; C Salvat; M Piechaczyk
Journal:  J Biol Chem       Date:  1995-05-12       Impact factor: 5.157

4.  Nuclear preservation and cytoplasmic degradation of human immunodeficiency virus type 1 Rev protein.

Authors:  S Kubota; L Duan; R A Furuta; M Hatanaka; R J Pomerantz
Journal:  J Virol       Date:  1996-02       Impact factor: 5.103

5.  Degradation of the proto-oncogene product c-Fos by the ubiquitin proteolytic system in vivo and in vitro: identification and characterization of the conjugating enzymes.

Authors:  I Stancovski; H Gonen; A Orian; A L Schwartz; A Ciechanover
Journal:  Mol Cell Biol       Date:  1995-12       Impact factor: 4.272

6.  Flexibility: the key to p53 function?

Authors:  J Milner
Journal:  Trends Biochem Sci       Date:  1995-02       Impact factor: 13.807

7.  Accumulation of p53 in a mutant cell line defective in the ubiquitin pathway.

Authors:  D R Chowdary; J J Dermody; K K Jha; H L Ozer
Journal:  Mol Cell Biol       Date:  1994-03       Impact factor: 4.272

8.  The jun and fos protein families are both required for cell cycle progression in fibroblasts.

Authors:  K Kovary; R Bravo
Journal:  Mol Cell Biol       Date:  1991-09       Impact factor: 4.272

Review 9.  Relationship of p53 to the control of apoptotic cell death.

Authors:  M Oren
Journal:  Semin Cancer Biol       Date:  1994-06       Impact factor: 15.707

10.  UBA 1: an essential yeast gene encoding ubiquitin-activating enzyme.

Authors:  J P McGrath; S Jentsch; A Varshavsky
Journal:  EMBO J       Date:  1991-01       Impact factor: 11.598

View more
  7 in total

1.  The design of a hyperstable mutant of the Abp1p SH3 domain by sequence alignment analysis.

Authors:  A Rath; A R Davidson
Journal:  Protein Sci       Date:  2000-12       Impact factor: 6.725

Review 2.  Basic principles and emerging concepts in the redox control of transcription factors.

Authors:  Regina Brigelius-Flohé; Leopold Flohé
Journal:  Antioxid Redox Signal       Date:  2011-04-05       Impact factor: 8.401

3.  REG gamma: a potential marker in breast cancer and effect on cell cycle and proliferation of breast cancer cell.

Authors:  Xiaoyi Wang; Shengfen Tu; Jinxiang Tan; Tian Tian; Liang Ran; Jean-Francois Rodier; Guosheng Ren
Journal:  Med Oncol       Date:  2010-05-14       Impact factor: 3.064

4.  Dual mechanisms of CYP3A protein regulation by proinflammatory cytokine stimulation in primary hepatocyte cultures.

Authors:  Choon-Myung Lee; Jan Pohl; Edward T Morgan
Journal:  Drug Metab Dispos       Date:  2009-01-26       Impact factor: 3.922

5.  Inhibitory effect of ubiquitin-proteasome pathway on proliferation of esophageal carcinoma cells.

Authors:  Wei-Guo Zhang; Jie-Ping Yu; Qing-Ming Wu; Qiang Tong; Sheng-Bao Li; Xiao-Hu Wang; Guo-Jian Xie
Journal:  World J Gastroenterol       Date:  2004-10-01       Impact factor: 5.742

6.  The proteasome is an integral part of solar ultraviolet a radiation-induced gene expression.

Authors:  Betul Catalgol; Isabella Ziaja; Nicolle Breusing; Tobias Jung; Annika Höhn; Buket Alpertunga; Peter Schroeder; Niki Chondrogianni; Efstathios S Gonos; Isabelle Petropoulos; Bertrand Friguet; Lars-Oliver Klotz; Jean Krutmann; Tilman Grune
Journal:  J Biol Chem       Date:  2009-08-18       Impact factor: 5.157

Review 7.  The emerging roles of GPRC5A in diseases.

Authors:  Honglei Zhou; Isidore Rigoutsos
Journal:  Oncoscience       Date:  2014-11-25
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.